Literature DB >> 17030845

Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.

Thomas J Chambers1, Xiaoshan Jiang1, Deborah A Droll1, Yan Liang1, William S M Wold1, Janice Nickells1.   

Abstract

A molecular clone of Japanese encephalitis virus (JE virus) was derived from the JE virus Nakayama strain and used to produce infectious JE virus in cell culture. The engineered JE virus resembled the parental JE virus in cell-culture properties and was related closely to other JE virus strains based on nucleotide sequence analysis. The JE virus clone was used as a genetic background for construction of a chimeric virus containing the structural proteins prM and E of Dengue virus, serotype 2. The chimeric JE/dengue 2 virus generated authentic dengue 2 structural proteins as assessed by immunoassays for the dengue E protein. It exhibited a small plaque size and less efficient growth in various cell lines than the parental JE virus. JE/dengue 2 virus was non-neuroinvasive for young adult mice, but displayed partial neurovirulence at doses up to 4 log p.f.u. given intracerebrally. Immunization of 3-week-old mice with JE/dengue 2 virus yielded neutralizing-antibody titres against dengue 2 virus and conferred protection against dengue encephalitis caused by neuroadapted dengue 2 virus. A rise in post-challenge neutralizing-antibody titres against dengue 2 virus in surviving mice suggests that immunization is associated with establishment of a memory antibody response in this model. This study demonstrates the capacity of JE virus to serve as a vector for expression of heterologous flavivirus structural proteins. Similar to previous studies with other chimeric flaviviruses, this approach may be useful as a genetic system for engineering experimental vaccines against Dengue virus and other medically important flaviviruses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030845     DOI: 10.1099/vir.0.81909-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys.

Authors:  Joseph E Blaney; James Speicher; Christopher T Hanson; Neeraj S Sathe; Stephen S Whitehead; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2008-06-13       Impact factor: 3.641

3.  JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease.

Authors:  Thomas J Chambers; Deborah A Droll; Xiaoshan Jiang; William S M Wold; Janice A Nickells
Journal:  Virology       Date:  2007-05-22       Impact factor: 3.616

4.  Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.

Authors:  Joseph E Blaney; Neeraj S Sathe; Christopher T Hanson; Cai Yen Firestone; Brian R Murphy; Stephen S Whitehead
Journal:  Virol J       Date:  2007-02-28       Impact factor: 4.099

5.  Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.

Authors:  Jian Yang; Huiqiang Yang; Zhushi Li; Wei Wang; Hua Lin; Lina Liu; Qianzhi Ni; Xinyu Liu; Xianwu Zeng; Yonglin Wu; Yuhua Li
Journal:  Viruses       Date:  2017-01-21       Impact factor: 5.048

6.  Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool.

Authors:  Chee Wah Tan; Han Kang Tee; Michelle Hui Pheng Lee; I-Ching Sam; Yoke Fun Chan
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.